Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,618
datasets available to search
ShareScore release 0.9.0
Dataset results
1,618 results for “gemcitabine”
Trial Comparing Cisplatin With or Without Gemcitabine in Patients With Carcinoma of Unknown Primary
ClinicalTrials.gov study NCT00126269. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Combination Therapy of L19IL2 and Gemcitabine in Advanced Pancreatic Cancer Patients
ClinicalTrials.gov study NCT01198522. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Study of HS-20093 Versus Gemcitabine in Combination With Docetaxel in Treatment of Osteosarcoma After Previous Second-line Treatment Failure
ClinicalTrials.gov study NCT06935409. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Efficacy Study of P276-00 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer
ClinicalTrials.gov study NCT00898287. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Adjuvant Versus Progression-Triggered Gemcitabine Monotherapy for Locally Advanced Bladder Cancer
ClinicalTrials.gov study NCT00146276. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Gemcitabine and Demcizumab (OMP-21M18) With or Without Abraxane® as 1st-line Treatment in Subjects With Locally Advanced or Metastatic Pancreatic Cancer
ClinicalTrials.gov study NCT01189929. IPD Sharing: Not stated. Countries: 3. Publications: 0.
ADVANCED Phase II Trial of Weekly vs 3 Weekly Docetaxel and Cisplatin Followed by Gemcitabine in Non-small-cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT00424853. IPD Sharing: Not stated. Countries: 1. Publications: 0.
BMS-247550 and Gemcitabine in Treating Patients With Advanced Solid Tumors
ClinicalTrials.gov study NCT00043095. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase II Trial to Evaluate Gemcitabine and Etoposide for Locally Advanced or Metastatic Pancreatic Cancer
ClinicalTrials.gov study NCT00202800. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Epcoritamab, Rituximab, Gemcitabine and Oxaliplatin (R-GemOx) as Salvage Therapy Before Autologous Stem Cell Transplant for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT07365306. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Vantictumab (OMP-18R5) in Combination With Nab-Paclitaxel and Gemcitabine in Previously Untreated Stage IV Pancreatic Cancer
ClinicalTrials.gov study NCT02005315. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Toripalimab Plus Lenvatinib and Gemcitabine-based Chemotherapy in 1L Treatment of Advanced ICC: a Phase III Study
ClinicalTrials.gov study NCT05342194. IPD Sharing: NO. Countries: 1. Publications: 0.
Arsenic Trioxide in Treating Patients With Pancreatic Cancer That Has Not Responded to Gemcitabine
ClinicalTrials.gov study NCT00053222. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study Comparing BMS-986504 in Combination With Nab-paclitaxel and Gemcitabine Versus Placebo in Combination With Nab-paclitaxel and Gemcitabine in Participants With Untreated Metastatic Pancreatic D
ClinicalTrials.gov study NCT07076121. IPD Sharing: YES. Countries: 36. Publications: 0.
Effect on Tumor Perfusion of a Chemotherapy Combining Gemcitabine and Vismodegib Before Surgery in Pancreatic Cancer
ClinicalTrials.gov study NCT01713218. IPD Sharing: Not stated. Countries: 1. Publications: 0.
MK0752 and Gemcitabine Hydrochloride in Treating Patients With Stage III and IV Pancreatic Cancer That Cannot Be Removed by Surgery
ClinicalTrials.gov study NCT01098344. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Gemcitabine, Docetaxel, and Capecitabine in Treating Patients With Cancer of Unknown Primary Origin
ClinicalTrials.gov study NCT00119314. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Gemcitabine and Capecitabine to Treat Patients With Advanced Pancreatic and Biliary Cancers
ClinicalTrials.gov study NCT00626158. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Efficacy Evaluation of iAPA-DC/CTL Combined Gemcitabine Therapy on Advanced Pancreatic Cancer
ClinicalTrials.gov study NCT02529579. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Enzalutamide in Combination With Gemcitabine and Nab-Paclitaxel for the Treatment of Advanced Pancreatic Cancer
ClinicalTrials.gov study NCT02138383. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.